Coronavirus pathogenesis in mice explains the SARS-CoV-2 multi-organ spread by red blood cell hitch-hiking
暂无分享,去创建一个
F. Rodríguez | G. Gueron | F. Gentile | E. A. Zizzi | A. Costábile | Á. Fajardo | M. Crispo | G. Moratorio | A. Cherkasov | P. Moreno | J. Pórfido | M. Pereira-Gómez | P. Sanchis | N. Anselmino | S. Lage-Vickers | Agustina Ayelen Sabater | J. Bizzotto | J. Cotignola | N. Navone | E. Vazquez | N. Nin | A. Toro | G. Pascual | A. Arévalo | R. Seniuk | D. Alonso | I. Achinelli | L. Estefanía
[1] J. F. Morton,et al. Duration of viral infectiousness and correlation with symptoms and diagnostic testing in non-hospitalized adults during acute SARS-CoV-2 infection: A longitudinal cohort study , 2022, Journal of Clinical Virology.
[2] S. Pittaluga,et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy , 2022, Nature.
[3] G. Lippi,et al. Age, Sex and Previous Comorbidities as Risk Factors Not Associated with SARS-CoV-2 Infection for Long COVID-19: A Systematic Review and Meta-Analysis , 2022, Journal of clinical medicine.
[4] D. Imhof,et al. Host and viral proteins involved in SARS‐CoV‐2 infection differentially bind heme , 2022, Protein science : a publication of the Protein Society.
[5] Ali I. Al-Gareeb,et al. Hemolytic anemia in COVID-19 , 2022, Annals of Hematology.
[6] Nicola Clementi,et al. Unconventional CD147‐dependent platelet activation elicited by SARS‐CoV‐2 in COVID‐19 , 2021, Journal of Thrombosis and Haemostasis.
[7] S. Bhatia,et al. CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target , 2021, Science of The Total Environment.
[8] M. Dimopoulos,et al. Late‐onset hematological complications post COVID‐19: An emerging medical problem for the hematologist , 2021, American journal of hematology.
[9] Thamil Vaani Komarasamy,et al. Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword , 2021, Frontiers in Immunology.
[10] Carolina Q. Sacramento,et al. SARS-CoV-2 Proteins Bind to Hemoglobin and Its Metabolites , 2021, International journal of molecular sciences.
[11] S. Soltani,et al. Role of Glycoprotein Hemagglutinin-Esterase in COVID-19 Pathophysiology? , 2021, Stem Cell Reviews and Reports.
[12] M. Malim,et al. SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity , 2021, SciAdv.
[13] R. Jayadevan,et al. Long COVID: An overview , 2021, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.
[14] M. Bollati-Fogolín,et al. Ivermectin reduces in vivo coronavirus infection in a mouse experimental model , 2021, Scientific Reports.
[15] M. Malim,et al. SARS-CoV-2 recruits a haem metabolite to evade antibody immunity , 2021, medRxiv : the preprint server for health sciences.
[16] Zhaohui Zheng,et al. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells , 2020, Signal Transduction and Targeted Therapy.
[17] M. Marshall. The lasting misery of coronavirus long-haulers , 2020, Nature.
[18] K. Sahu,et al. COVID‐19 related immune hemolysis and thrombocytopenia , 2020, Journal of medical virology.
[19] E. Mahabir,et al. Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2 , 2020, Viruses.
[20] L. Platanias,et al. Hematological manifestations of COVID-19 , 2020, Leukemia & lymphoma.
[21] R. Romero-Ortuño,et al. A pharmacological perspective of chloroquine in SARS-CoV-2 infection: An old drug for the fight against a new coronavirus? , 2020, International Journal of Antimicrobial Agents.
[22] A. Korganow,et al. Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine , 2020, Frontiers in Immunology.
[23] X. Bian. Autopsy of COVID-19 patients in China , 2020, National science review.
[24] Á. Fajardo,et al. Evaluation of SYBR Green real time PCR for detecting SARS-CoV-2 from clinical samples , 2020, bioRxiv.
[25] H. Shan,et al. Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19 , 2020, medRxiv.
[26] H. Ulrich,et al. CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement , 2020, Stem Cell Reviews and Reports.
[27] Amber Dance. What is a cytokine storm? , 2020 .
[28] D. Raoult,et al. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? , 2020, International Journal of Antimicrobial Agents.
[29] Sharon Einav,et al. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19 , 2020, Journal of Critical Care.
[30] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[31] S. Dahl. The Role of Red Blood Cells in Hemostasis , 2016 .
[32] S. Jeong,et al. Loss of CD147 results in impaired epithelial cell differentiation and malformation of the meibomian gland , 2015, Cell Death and Disease.
[33] S. Weiss,et al. Expression of Hemagglutinin Esterase Protein from Recombinant Mouse Hepatitis Virus Enhances Neurovirulence , 2005, Journal of Virology.
[34] N. Seidah,et al. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread , 2005, Virology Journal.
[35] Fyaz M. D. Ismail,et al. Mapping antimalarial pharmacophores as a useful tool for the rapid discovery of drugs effective in vivo: design, construction, characterization, and pharmacology of metaquine. , 2005, Journal of medicinal chemistry.
[36] N. Surolia,et al. Interaction of chloroquine and its analogues with heme: An isothermal titration calorimetric study. , 2000, Biochemical and biophysical research communications.
[37] B. Maupin. [Platelets and viruses]. , 1966, Hemostase.